Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008


Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET)

2007 Financial Highlights

- Total BioMarin revenue of $121.6 million

- Naglazyme net product revenue of $86.2 million, an increase of 85.4

percent over 2006 and above BioMarin's guidance range of $82 million

to $84 million

- Aldurazyme net product revenue of $123.7 million, an increase of 28.5

percent over 2006 and toward the upper end of BioMarin's guidance

range of $115 million to $125 million

- Net loss of $15.8 million, within the guidance range of a loss of $13

million to $18 million

- Net income of $2.6 million in the fourth quarter of 2007

2008 Financial Guidance

- Total BioMarin revenue in the range of $255 million to $306 million

which includes total product revenue of $213 million to $264 million

- Naglazyme net product revenue in the range of $105 million to $116

million

- Aldurazyme net product sales by Genzyme of $135 million to $145

million with net revenue to BioMarin from royalties and transfers of

inventory in the range of $68 million to $78 million

- Improved Kuvan net product revenue guidance in the range of $40

million to $70 million

- GAAP net income in the range of $20 million to $40 million and

non-GAAP net income in the range of $47 million to $67 million

NOVATO, Calif., Feb. 26 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced financial results for the fourth quarter and full year ended December 31, 2007. Net income was $2.6 million ($0.03 per share) for the fourth quarter of 2007, compared to a net loss of $10.4 million ($0.11 per share) for the fourth quarter of 2006. Net income for the fourth quarter of 2007 includes the receipt of the $15.0 million milestone payment from Merck Serono related to
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Empire Genomics announced ... a patent pending novel genomic biomarker from Cornell ... test that could help in diagnosing and determining ... Neuroendocrine prostate cancer (NEPC) is ... can arise de novo, but more commonly arises ...
(Date:5/22/2013)... AudioNotch is the leading ... AudioNotch is pleased to announce a partnership with ... both British Columbia and Alberta, Destination Hearing is ... AudioNotch's tinnitus treatment program is now available at ... Hearing clinic, patients have the detection of their ...
(Date:5/22/2013)... FL (PRWEB) May 22, 2013 A recent ... of probiotics on athletes to find that those who took ... longer. The results from the study showed that in extreme ... Action, known for their adult acne treatment explains ... and how it may help their skin condition. , ...
(Date:5/21/2013)... NEW YORK , May 21, 2013  The Lindsley ... announced today that it is a Grand Challenges Explorations ... Melinda Gates Foundation .  Dr. Sara Lustigman ... an innovative global health and development research project, titled ... worms.  These worms are needed to screen drugs to ...
Breaking Biology Technology:Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3
... - This week, the clock starts ticking on the ... installation work on the city's wireless Internet service. , ,After ... such as EarthLink and Cellnet , Mayor ... Midwest Fiber access to city facilities to build a $20 ...
... many large public companies are well into the third ... over financial reporting internal controls, this is a good ... In speaking across the United States on good internal ... CFOs, controllers, and internal auditors exactly how painful implementing ...
... Madison, Wis. - NimbleGen Systems, Inc. , ... preparing to access new markets through newly obtained intellectual ... Clara, Calif. firm , ,The license agreement will allow ... related instruments and software, covered by Affymetrix patents. , ...
Cached Biology Technology:Milwaukee could be wireless in 18 months 2The Big Picture of SOX 404 2The Big Picture of SOX 404 3The Big Picture of SOX 404 4NimbleGen extends research market reach 2
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, ... order to infect us, this pathogen has developed a ... unnoticed in our cells, thus avoiding these acting against ... biosciences research centre, CIC bioGUNE, in which teams from ... and the National Supercomputation Centre in Barcelona (BSC) have ...
(Date:5/21/2013)... have known for a long time that some creatures ... understood, particularly for plants. But it may be that ... National University and the U. S. National Evolutionary Synthesis ... 21 May in the journal Nature Communications , ... genomes. , Drawing from a database of global patterns ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... college students who understand the geological age of the Earth ... accept human evolution, according to a University of Minnesota study ... . The finding could give educators a new strategy ... in physical rather than biological science classes. Researchers Sehoya ...
... Ala. Discovery of an antibiotic,s capacity to improve ... researchers with leads to more desirable molecules with potentially ... a paper publishing March 10 in the journal ... that this discovery serves as the impetus for a ...
... climate change could swiftly exacerbate drought in many parts ... to mass displacements of people, water and food shortages, ... To compare drought impact and mitigation at the international ... three-day meeting this month that will bring together senior ...
Cached Biology News:Students' perceptions of Earth's age influence acceptance of human evolution, says U of Minn. study 2Movement disorder symptoms are lessened by an antibiotic 2Movement disorder symptoms are lessened by an antibiotic 3UC Riverside to host 3-day international meeting on drought 2
UBC13 Antibody...
... Kit Kit Includes: Phospho- ... ul SAPK/JNK (56G8) Rabbit mAb, Catalog ... Catalog #9253, (4 Western mini-blots) Anti-rabbit ... ul Anti-biotin IgG, HRP-linked Antibody, Catalog ...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
...
Biology Products: